Teleflex(TFX) - 2022 Q4 - Earnings Call Presentation

Q4 2022 Performance - Q4 2022 constant currency revenue included strong performances from Interventional, Surgical, and OEM[17] - Q4 2022 adjusted EPS was $3.52, a ~2% decline year-over-year, including headwinds from incremental inflation and FX[17] - Q4 2022 constant currency revenue grew 3.7% year-over-year, including impact of a 60bp decline in MSTA revenue associated with respiratory divestiture[30] - Consolidated revenue decreased 0.5% year-over-year on a GAAP basis to $758 million[20, 37] - Consolidated revenue increased 3.7% year-over-year on a constant currency basis[20, 37] 2023 Financial Guidance - Establishing 2023 constant currency revenue growth guidance of 4.75% to 6.25%[17] - Setting 2023 adjusted earnings per share guidance of $13.00 to $13.60[31] - 2023 GAAP Revenue Growth is forecasted between 4.25% and 5.75%[50] - Impact of Foreign Exchange Rate Fluctuations is estimated at (0.50)%[50] 2022 Financial Review - 2022 revenue decreased (0.7)% year-over-year on a GAAP basis to $2,791 million[82, 85] - 2022 revenue increased 2.9% year-over-year on a constant currency basis[82, 85]